1. Home
  2. PBHC vs ACET Comparison

PBHC vs ACET Comparison

Compare PBHC & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

HOLD

Current Price

$14.34

Market Cap

87.8M

Sector

Finance

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.00

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBHC
ACET
Founded
1859
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.8M
71.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PBHC
ACET
Price
$14.34
$8.00
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$96.67
AVG Volume (30 Days)
3.1K
199.8K
Earning Date
01-30-2026
03-05-2026
Dividend Yield
2.81%
N/A
EPS Growth
N/A
N/A
EPS
1.07
N/A
Revenue
$44,154,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.35
N/A
Revenue Growth
24.40
N/A
52 Week Low
$13.35
$7.15
52 Week High
$17.50
$17.44

Technical Indicators

Market Signals
Indicator
PBHC
ACET
Relative Strength Index (RSI) 51.18 75.57
Support Level $13.96 $7.70
Resistance Level $14.38 $8.56
Average True Range (ATR) 0.30 0.53
MACD 0.06 -0.01
Stochastic Oscillator 86.08 23.78

Price Performance

Historical Comparison
PBHC
ACET

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: